Ocular albinism is managed symptomatically with low vision aids, tinted glasses, colored glasses and by drugs which increase plasma tyrosine levels thereby increasing eye pigmentation.
Studies show that Nitisinone elevates plasma tyrosine levels and seems to be effective in hereditary tyrosinemia, but how far it is effective in treating ocular albinism is yet to be established.
A small pilot study revealed that the drug nitisinone increases melanin production in people with oculocutaneous albinism type 1B (OCA-1B), which could help in protecting individuals with the condition against the ultraviolet rays from sunlight and also may help in the development of normal vision.